Effect of the Height of the Operating Table During Spinal Anesthesia

NCT02373410 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-02-27

No results posted yet for this study

Summary

The purpose of this study is to analyze the accuracy of needle insertion and the discomfort during different ergonomic conditions faced by anesthesiologists during spinal anesthesia. In particular,the investigators intend to compare the angles between the patients' back and the inserted spinal needle in the coronal plane at different operating table heights.

Conditions

  • Anesthesia, Spinal [E03.155.086.331]
  • Operating Tables [E07.325.662]

Interventions

PROCEDURE

Umbilicus

Depending on the height of the operating table, the insertion angle of the spinal needles would be vary. The investigators intend to find the optimal angle and the height of the table to provide that. The height of the operating table which set at the needle insertion point of anesthetists; the level of umbilicus

PROCEDURE

Lowest rib margin

The height of the operating table which set at the needle insertion point of anesthetists; the level of lowest rib margin

PROCEDURE

Xiphoid

The height of the operating table which set at the needle insertion point of anesthetists; the level of xiphoid

PROCEDURE

Nipple

The height of the operating table which set at the needle insertion point of anesthetists; the level of nipple

DRUG

Umbilicus Bupivacaine

If freely flowing of CSF is detected, appropriate dose of MARCAINE was injected in all interventional groups.

DRUG

Lowest rib margin Bupivacaine

If freely flowing of CSF is detected, appropriate dose of MARCAINE was injected in all interventional groups.

DRUG

Xiphoid Bupivacaine

If freely flowing of CSF is detected, appropriate dose of MARCAINE was injected in all interventional groups.

DRUG

Nipple Bupivacaine

If freely flowing of CSF is detected, appropriate dose of MARCAINE was injected in all interventional groups.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Jinhee Kim, MD,PhD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02373410 on ClinicalTrials.gov